Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nunzio Bottini

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Current Rheumatology Reports|April 12, 2017
Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic TargetsCristiano Sacchetti, Nunzio Bottini
American Journal of Physiology. Cell Physiology|April 27, 2022
Emerging proteoglycans and proteoglycan-targeted therapies in rheumatoid arthritisBrianna Hurysz, Nunzio Bottini
Nature Reviews. Rheumatology|September 23, 2015
Decade in review-translational rheumatology: Ten years after: rheumatology research from bench to bedsideNunzio Bottini, Gary S Firestein
Nature Reviews. Rheumatology|July 9, 2014
PTPN22: the archetypal non-HLA autoimmunity geneStephanie M Stanford, Nunzio Bottini
Cell Research|August 2, 2014
"PEST control": regulation of molecular barcodes by tyrosine phosphatasesKaren M Doody, Nunzio Bottini
Nature Reviews. Rheumatology|November 14, 2012
Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressorsNunzio Bottini, Gary S Firestein
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2023
Inhibiting the Inhibitor in Synovial Macrophages and Cancer Immunotherapy-Associated Inflammatory ArthritisNisarg J Shah, Nunzio Bottini
Annual Review of Immunology|December 25, 2013
Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and diseaseNunzio Bottini, Erik J Peterson
Nature Reviews. Drug Discovery|January 24, 2023
Targeting protein phosphatases in cancer immunotherapy and autoimmune disordersStephanie M Stanford, Nunzio Bottini
Trends in Pharmacological Sciences|April 17, 2017
Targeting Tyrosine Phosphatases: Time to End the StigmaStephanie M Stanford, Nunzio Bottini
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Current Rheumatology Reports|April 12, 2017
Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic TargetsCristiano Sacchetti, Nunzio Bottini
American Journal of Physiology. Cell Physiology|April 27, 2022
Emerging proteoglycans and proteoglycan-targeted therapies in rheumatoid arthritisBrianna Hurysz, Nunzio Bottini
Nature Reviews. Rheumatology|September 23, 2015
Decade in review-translational rheumatology: Ten years after: rheumatology research from bench to bedsideNunzio Bottini, Gary S Firestein
Nature Reviews. Rheumatology|July 9, 2014
PTPN22: the archetypal non-HLA autoimmunity geneStephanie M Stanford, Nunzio Bottini
Cell Research|August 2, 2014
"PEST control": regulation of molecular barcodes by tyrosine phosphatasesKaren M Doody, Nunzio Bottini
Nature Reviews. Rheumatology|November 14, 2012
Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressorsNunzio Bottini, Gary S Firestein
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2023
Inhibiting the Inhibitor in Synovial Macrophages and Cancer Immunotherapy-Associated Inflammatory ArthritisNisarg J Shah, Nunzio Bottini
Annual Review of Immunology|December 25, 2013
Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and diseaseNunzio Bottini, Erik J Peterson
Nature Reviews. Drug Discovery|January 24, 2023
Targeting protein phosphatases in cancer immunotherapy and autoimmune disordersStephanie M Stanford, Nunzio Bottini
Trends in Pharmacological Sciences|April 17, 2017
Targeting Tyrosine Phosphatases: Time to End the StigmaStephanie M Stanford, Nunzio Bottini
Pageof 15